In the context of melanoma, pre-clinical investigations have demonstrated that the plasma membrane calcium ATPase PMCA4 inhibits the migration and metastatic activity of BRAF-mutant melanoma cells [37]. The gene discussed is ATP2B4; the disease is melanoma.